• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BELLUS Health Inc

+ Add to Watchlist

BLUSF:US

1.2438 USD 0.0038 0.31%

As of 20:10:01 ET on 12/18/2014.

Snapshot for BELLUS Health Inc (BLUSF)

Open: 1.2436 Day's Range: 1.2436 - 1.2438 Volume: 700
Previous Close: 1.2400 52wk Range: 0.3560 - 1.6600 1-Yr Rtn: +234.24%

Stock Chart for BLUSF

No chart data available.
  • BLUSF:US 1.2438
  • 1D
  • 1M
  • 1Y
1.2400
Interactive BLUSF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLUSF

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2013) -
Est. PEG Ratio -
Market Cap (M USD) 58.99
Shares Outstanding (M) 47.43
30 Day Average Volume 2,727
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLUSF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for BLUSF

BELLUS Health Inc. develops drugs for rare diseases, including conditions that affect the kidneys. The Company's main operations are in a Phase III Confirmatory Study for the treatment of AA amyloidosis. BELLUS is also developing treatments for sarcoidosis and hemolytic uremic syndrome.

Roberto BelliniPresident/CEODenis GarceauSenior VP:Drug Development
Francois DesjardinsVP:FinanceTony MatzouranisVP:Business Development
More Company Profile & Key Executives for BLUSF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil